Study guide

6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations

Mississippi MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Mississippi MPJE Overview

1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight

2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure

2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring

3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority

3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records

4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security

4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols

5 Chapter 5: Dispensing Controlled Substances & Prescription Processing

5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose

6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates

6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi

7 Chapter 7: Pharmacy Operations, Permits & Facilities

7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines

8 Chapter 8: Compounding Standards, Safety & Product Selection

8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications

9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations

9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps

6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations

Key Takeaways Explain This Topic AI

Mississippi’s current § 73-21-124 permits regulated behind-the-counter nonprescription sales subject to 3.6 grams per day and 7.2 grams per 30 days.

The purchaser must be at least 18 and present one of the statute’s accepted government identification documents; the seller records and submits the transaction through NPLEx.

The product is kept behind a counter or in a locked display and the purchaser completes the required electronic or written acknowledgment.

An NPLEx stop-sale response blocks the sale; the current override is limited to a seller’s reasonable fear of imminent bodily harm and must follow the statutory process.

A person identified as a resident of a jurisdiction where pseudoephedrine is prescription-only must present a valid prescription as the current Mississippi statute provides.

Last updated: August 2026

Mississippi Pseudoephedrine and Ephedrine Sales

Mississippi Miss. Code Ann. § 73-21-124 , as amended effective April 23, 2025, regulates nonprescription retail sale of products containing pseudoephedrine or ephedrine. The current statute permits behind-the-counter access under stricter quantity and electronic-tracking controls. It is scheduled for repeal on July 1, 2029 unless changed, so future candidates must check the live statute.

Placement and seller controls

Covered products are kept behind a counter or in a locked display so customers cannot directly remove them. The seller verifies eligibility and submits the transaction to the National Precursor Log Exchange (NPLEx) . The system check occurs before completion; a point-of-sale receipt after handing over product is not enough.

The purchaser must be at least 18 years old and provide an accepted government-issued identification document. The seller records the required identity, product, quantity, date/time, and transaction data. The purchaser provides the electronic or written acknowledgment required by the statute. Information is used and disclosed only as authorized.

Quantity limits

Mississippi permits no more than:

3.6 grams of pseudoephedrine or ephedrine base in a day ; and

7.2 grams in a 30-day period .

Both limits apply. A requested 2.4-gram package is not lawful if prior purchases would make the 30-day total 7.8 grams. Federal law’s general retail 9-gram 30-day ceiling does not enlarge Mississippi’s 7.2-gram cap.

Calculate grams of base from the product and package, not the number of boxes. Combination products count. Do not add an unsupported 48-gram annual limit to the current Mississippi rule unless the live statute actually imposes it.

Stop-sale and safety override

When NPLEx returns a stop-sale alert , the seller does not complete the sale. The current Mississippi safety override is narrow: it applies when the seller has a reasonable fear of imminent bodily harm if the transaction is denied, and the seller follows the statutory override and documentation process. Professional judgment that a patient “probably needs the medicine,” familiarity with the customer, system inconvenience, or a verbal prescriber recommendation is not the statutory override.

If NPLEx is unavailable, follow the current downtime procedure rather than completing an unlogged sale from memory. The pharmacy should preserve system confirmations and train staff on escalation.

Residents of prescription-only jurisdictions

The current law addresses identification showing residence in a state or jurisdiction that requires a prescription for pseudoephedrine. That purchaser must present a valid prescription as the statute provides. Do not assume every adult visitor gets the nonprescription pathway merely because Mississippi generally permits BTC sale.

Prescription dispensing

A valid prescription is dispensed under ordinary prescription rules rather than treated as a nonprescription BTC purchase, though applicable reporting and pharmacy records remain. A prescription does not authorize unlimited quantities or a sale outside prescriber scope.

Exam method

Check five gates: product placement, age and accepted ID, residence rule, package and cumulative grams, and NPLEx response. Remember 18; 3.6 grams/day; 7.2 grams/30 days; stop-sale unless the imminent-bodily-harm override applies . The statute’s 2025 amendment and 2029 repeal date are reminders to reject older “Mississippi is universally prescription-only” summaries.

Cumulative-sale examples

A purchaser has bought 3.0 grams earlier today and requests 1.2 grams. The daily total would be 4.2 grams, so refuse even if the 30-day total remains below 7.2. Another purchaser has no purchase today but 6.0 grams in the prior 30 days and requests 1.2; a total of exactly 7.2 fits the quantity ceiling if every other requirement and NPLEx response is satisfied.

A store clerk may conduct the transaction only under the direct supervision and control required by the current statute; the pharmacy remains responsible for correct ID, age, base-gram calculation, acknowledgment, and NPLEx submission. If the system blocks the sale, manager approval, customer familiarity, or a small package cannot substitute for the imminent-bodily-harm override standard.

Residence and ID drill

An unexpired accepted ID establishes age and residence for the statutory process; an expired or suspended credential does not satisfy the current requirement. If the ID identifies a prescription-only jurisdiction, stop the nonprescription pathway and require a valid prescription. If identity data fail to match NPLEx, resolve the mismatch rather than creating a second profile. Keep the product behind the pharmacy counter throughout the transaction, and do not hand it to the purchaser until the system permits completion and all acknowledgments are captured.

Loading diagram... 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations — Current Rule Map